Expand DGX Menu
DGX MENU

Quest Diagnostics (DGX) closed at $259.60 on November 13, 2026, unchanged from the previous close, on volume of 604,127 shares (30-day average 947,171).

Key numbers
  • Last close: $259.60 (November 13, 2026)
  • 52-week range: $171.18 to $262.00
  • Market value: $28.7 billion
  • 30-day implied volatility (IV30): 26.7%
  • Option volume: 210 contracts (126 calls, 84 puts); 30-day average 622

Data as of November 13, 2026.

DGX Stock Summary and Trading Ideas (Quest Diagnostics | NYSE:DGX)

Charts for Today's Stock Price and Implied Volatility in Quest Diagnostics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for DGX by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Oct 20, 2026 Put Spread 20-Nov-26220 : 240 P 814
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days

Trading Statistics

Key Ratios

Quest Diagnostics (DGX) Frequently Asked Questions

What does Quest Diagnostics do?

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

What symbol and exchange does Quest Diagnostics shares trade?

Quest Diagnostics trades on the NYSE stock market under the symbol DGX.

What is Quest Diagnostics stock price doing today?

As of November 16, 2026, DGX stock price climbed to $261.70 with 326,715 million shares trading.

What is Quest Diagnostics's Beta?

DGX has a beta of -0.43, meaning it tends to be less sensitive to market movements. DGX has a correlation of 0.05 to the broad based SPY ETF.

How much is Quest Diagnostics worth?

DGX has a market cap of $28.88 billion. This is considered a Large Cap stock.

How much money does Quest Diagnostics make?

Last quarter Quest Diagnostics reported $3 billion in Revenue and $3.00 earnings per share. This beat revenue expectation by $47 million and exceeded earnings estimates by $.13.

What is the highest and lowest price Quest Diagnostics traded in the last 3 year period?

In the last 3 years, DGX traded as high as $263.19 and as low as $123.04.

What are the top ETFs holding Quest Diagnostics?

The top ETF exchange traded funds that DGX belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

Is Quest Diagnostics (DGX) a good investment?

DGX has outperformed the market in the last year with a price return of +41.3% while the SPY ETF gained +11.1%. DGX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.2% and +3.9%, respectively, while the SPY returned -4.8% and -2.2%, respectively.

What are the support and resistance levels for Quest Diagnostics (DGX)?

DGX support price is $255.59 and resistance is $263.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DGX shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes